BNR · Burning Rock Biotech Ltd
Market Cap
$107.47M
Shares
10.55M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|
| shares | 0 | 0 | 2.35M | 2.24M |
| shares | 0 | 0 | 2.35M | 2.24M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (CNY)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Inhospital Business | 224,035,000 | 224,492,000 | 188,701,000 | 175,296,000 | 165,116,000 | 117,872,000 | 87,678,000 |
| Central Laboratory Business | 159,993,000 | 175,649,000 | 232,812,000 | 314,770,000 | 319,353,000 | 297,342,000 | 276,254,000 |
| Pharma Research and Development Services | 155,540,000 | 115,681,000 | 115,922,000 | 73,172,000 | 23,393,000 | 14,689,000 | 17,745,000 |
By Geography (CNY)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| China | 510,241,000 | 534,928,000 | 553,304,000 | 504,052,000 | 429,903,000 |
| United States | 5,581,000 | 2,507,000 | 9,934,000 | 3,810,000 | 0 |
By Product & Service (CNY)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Service | 316,111,000 | 290,738,000 | 345,030,000 | 391,548,000 | 342,465,000 | 311,184,000 | 292,523,000 |
| Product | 223,457,000 | 225,084,000 | 192,405,000 | 171,690,000 | 165,397,000 | 118,719,000 | 89,154,000 |
Key facts
CIK
1792267
CUSIP
12233L206
13F (30d)
15 filings
15 filers
Visit website
Investor relations